Replies to post #207906 on Cytodyn Inc (CYDY)

[HyGro]

Cash flow analysis shows they are likely to run out of cash in May. They can't afford trials, likely won't continue the FDA stopped trials. Owe $~100m to Samsung and vulture fund they are past due on. They can't raise much money - Paulson private placements only generated ~$4m when they offered ~$50m.

Go ahead and buy more. It's cheap.